Latest News
Active management and a charitable mission drive Simplify's 42% gain, but iShares offers lower costs and higher dividend income for conservative investors.
Via The Motley Fool · August 13, 2026
The company's double miss on second-quarter estimates came amid relative weakness in precious metal prices.
Via The Motley Fool · August 13, 2026
Canadian Tire (TSX:CTC.A) looks like a durable retailer going for cheap with a strong dividend.
Via The Motley Fool · August 13, 2026
Canadians can easily turn their TFSA into a cash machine to receive recurring income streams.
Via The Motley Fool · August 13, 2026
Brit exercised vested options and liquidated them at $65 per share via a pre-established Rule 10b5-1 trading plan.
Via The Motley Fool · August 13, 2026
The growth case for Archer Aviation is getting stronger.
Via The Motley Fool · August 13, 2026
Micron and Sandisk are primed to skyrocket.
Via The Motley Fool · August 13, 2026
Both stocks have been on similar trajectories since SpaceX went public.
Via The Motley Fool · August 13, 2026
Fidelity's broad, low-cost index approach goes head-to-head with an actively managed, mission-driven healthcare fund.
Via The Motley Fool · August 13, 2026
The pharmaceutical giant just increased its dividend by 3.1%, now paying $5.36 a share annually.
Via The Motley Fool · August 13, 2026
Silver delivered 70.7% returns over one year but swung 52% deeper in drawdowns. Gold's lower costs and stability appeal to risk-averse bullion investors.
Via The Motley Fool · August 13, 2026
Telesat (NASDAQ:TSAT) reported a second-quarter net loss of CAD 559 million as the satellite operator continued to invest in its Lightspeed low Earth orbit network, while its legacy geostationary-orbit business faced ongoing revenue pressure.
Chief Financial Officer Donald Tremblay said the quarter
Via MarketBeat · August 13, 2026
Valneva (NASDAQ:VALN) reported lower first-half revenue and wider losses for 2026, while maintaining its full-year sales outlook and emphasizing its cash position, restructuring measures and expectations for regulatory progress on its Lyme disease vaccine candidate with Pfizer.
CEO Thomas Lingelbac
Via MarketBeat · August 13, 2026
X-Energy (NASDAQ:XE) reported second-quarter 2026 revenue and grant income of $54.6 million, up 154% from a year earlier, as engineering activity increased under the U.S. Department of Energy’s Advanced Reactor Demonstration Program, or ARDP.
CEO Clay Sell also said the Department of Energy formall
Via MarketBeat · August 13, 2026
Docebo (NASDAQ:DCBO) is pursuing new growth initiatives across government, skills management, healthcare and artificial intelligence as it continues its shift toward larger enterprise customers, CFO Brandon Farber said at the Oppenheimer Technology Conference.
Farber described Docebo as a learning
Via MarketBeat · August 13, 2026
Saga Communications (NASDAQ:SGA) reported lower second-quarter revenue and operating income as declines in traditional advertising categories outweighed continued growth in its blended digital business.
For the quarter ended June 30, 2026, net revenue fell $1.8 million, or 6.5%, to $26.4 million fr
Via MarketBeat · August 13, 2026
SuperCom (NASDAQ:SPCB) reported second-quarter 2026 revenue of $8.1 million, up 13.3% from $7.1 million a year earlier, as the electronic monitoring and public safety technology provider cited expanding deployments in the U.S. and Europe.
President and Chief Executive Officer Ordan Trabelsi said th
Via MarketBeat · August 13, 2026
Stratasys (NASDAQ:SSYS) reported second-quarter 2026 revenue of $137.6 million, up 3.7% sequentially but roughly flat from $138.1 million a year earlier, as record consumables sales and growth in its Stratasys Direct production-parts business offset lower system revenue.
Chief Executive Officer Yoa
Via MarketBeat · August 13, 2026
SBC Medical Group (NASDAQ:SBC) said its second-quarter 2026 results reflected a reacceleration in growth following structural reforms undertaken in 2025, with adjusted EBITDA rising faster than revenue despite the effect of a weaker yen on reported results.
The company reported second-quarter reven
Via MarketBeat · August 13, 2026
Park Dental Partners (NASDAQ:PARK) reported second-quarter revenue growth of 5.1% and raised its revenue outlook for its existing business after first-half results came in modestly ahead of management’s expectations.
Revenue for the second quarter totaled $66.2 million, while revenue for the first
Via MarketBeat · August 13, 2026
OpenAI's IPO target is colliding with SoftBank's 2027 deadline.
Via The Motley Fool · August 13, 2026
The stock's valuation isn't all that high given its growth and dominance in the streaming industry.
Via The Motley Fool · August 13, 2026
The Coach and Kate Spade parent fell after issuing disappointing guidance for the new fiscal year.
Via The Motley Fool · August 13, 2026
Luxury apparel maker beats expectations, raises full-year guidance.
Via The Motley Fool · August 13, 2026
The Vanguard Information Technology ETF has more than doubled the gains of the S&P 500 thus far in 2026.
Via The Motley Fool · August 13, 2026